Showing 1 - 10 of 1,229
Persistent link: https://www.econbiz.de/10003344907
; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration …
Persistent link: https://www.econbiz.de/10003900852
Persistent link: https://www.econbiz.de/10013263463
Persistent link: https://www.econbiz.de/10011765364
Persistent link: https://www.econbiz.de/10011765417
Persistent link: https://www.econbiz.de/10011765425
Persistent link: https://www.econbiz.de/10012505539
With the ongoing trade normalisation process between India and Pakistan, opportunities to integrate have opened up between both countries. The pharmaceutical sector is crucial to health issues in developing economies and would be an ideal segment to focus on in improving trade relations between...
Persistent link: https://www.econbiz.de/10010404687
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...
Persistent link: https://www.econbiz.de/10003900791
Many politicians blame physician dispensing (PD) to increase health care expenditure and to undermine independence of drug prescription and income leading to a suboptimal medication. Therefore, PD is not allowed in most OECD countries. In Switzerland, PD is allowed in some regions depending on...
Persistent link: https://www.econbiz.de/10003900934